Lyxumia could expedite moving patients to final drug dose

09/12/2011 | Bloomberg

A study of 482 patients with diabetes who used Sanofi's experimental Lyxumia found the drug improved blood-glucose levels when the dosage was doubled after two weeks or increased over three weeks, experts reported at the European Association for the Study of Diabetes conference. The drug, which also helped patients lose weight, could help doctors more quickly advance patients to the ideal drug dosing.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT